Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Oct 01, 2007 (Vol. 27, No. 17)

EBI—AltsSplice Database of Alternative Spliced Events

  • Nicely organized database
  • None
One of the surprises of the human genome project was that the number of genes discovered was considerably fewer than most had expected. I mean, for gosh sakes, we are at the top of the biological kingdom aren’t we? Shouldn’t we have the most genes? Before anyone accuses me of being a species-ist, I should pull the tongue from my cheek and report a bit on some of the reasons for the low numbers. It turns out that genes are, of course, spliced in eukaryotes, so mixing and matching of optional coding sequences gives rise to an enormous number of possible unique sequences—a phenomenon that is the basis also for immune system diversity. Tracking alternative splicing of genes is therefore both important and daunting. EMBL/EBI’s AltSplice site is an excellent resource that provides visitors with an easy-to-use database full of alternative splicing information. A full page query form allows users to specify many parameters, including chromosome number, chromosome location, splice events, gene names, location of gene expression, and much more. A welcome research tool, well done.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good

*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.


GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

What Does Brexit Mean for Biotech?

Do you agree with the contention that Brexit will NOT have a long-term negative impact on the British biotech industry?

More »